找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

(版塊PHARMACOLOGY & PHARMACY(藥理學(xué)與藥學(xué))版塊期刊總數(shù):80)
1234下一頁(yè)
返 回
新窗
投票 ESCI期刊PHARMACIA 2024/2025影響因子:1.145 (PHARMACIA) (0428-0296). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging Sources Citation  ...234
Total Citations:445; 2023 JIF:1.145; JIFRank: 296/354 ; Rank-JIF: 296; Number-of-JIF:354; 5 Year JIF:1.105; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.2; Immediacy Index-dealt:0.213; 2023 JCI:0.36; JCI Rank: 278/354 ; Total Articles:104; JCI Quartile:Q4; JCI Percentile:21.61; Eigenfactor:0; Normalized Eigenfactor:0.076; Article Influence Score:0.111; JIF Percentile:16.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:134; % of Articles in Citable items:0.7761; Cited Half-Life:2.5; Citing Half-Life:6.8; % of OA Gold:0.9508; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Pharmacy 2024/2025影響因子:2.127 (PHARMACY-BASEL) (NULL). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging Sources Citation  ...234
Total Citations:2254; 2023 JIF:2.127; JIFRank: 222/354 ; Rank-JIF: 222; Number-of-JIF:354; 5 Year JIF:2.224; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.4; Immediacy Index-dealt:0.423; 2023 JCI:0.5; JCI Rank: 236/354 ; Total Articles:140; JCI Quartile:Q3; JCI Percentile:33.47; Eigenfactor:0.004; Normalized Eigenfactor:0.768; Article Influence Score:0.491; JIF Percentile:37.4; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:183; % of Articles in Citable items:0.765; Cited Half-Life:3.6; Citing Half-Life:6.9; % of OA Gold:0.9982; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE
投票 ESCI期刊Clinical Pharmacology-Advances and Applications 2024/2025影響因子:3.192 (CLIN PHARMACOL-ADV A) (1179-1438). (PHARMACO  ...234
Total Citations:529; 2023 JIF:3.192; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:2.601; 5 Year JIF Quartile:Q3; JIF Without Self Cites:3.1; Immediacy Index:0.3; Immediacy Index-dealt:0.308; 2023 JCI:0.51; JCI Rank: 232/354 ; Total Articles:7; JCI Quartile:Q3; JCI Percentile:34.6; Eigenfactor:0; Normalized Eigenfactor:0.107; Article Influence Score:0.665; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:11; % of Articles in Citable items:0.6364; Cited Half-Life:6.7; Citing Half-Life:7.9; % of OA Gold:1; Publisher name:SPRINGER HEIDELBERG; Publisher address:TIERGARTENSTRASSE 17, HEIDELBERG, GERMANY, D-691
投票 ESCI期刊JAC-Antimicrobial Resistance 2024/2025影響因子:3.768 (JAC-ANTIMICROB RESIS) (NULL). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))  ...234
Total Citations:1419; 2023 JIF:3.768; JIFRank: 90/354 ; Rank-JIF: 90; Number-of-JIF:354; 5 Year JIF:3.962; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.5; Immediacy Index:0.4; Immediacy Index-dealt:0.451; 2023 JCI:0.73; JCI Rank: 154/354 ; Total Articles:135; JCI Quartile:Q2; JCI Percentile:57.45; Eigenfactor:0.003; Normalized Eigenfactor:0.705; Article Influence Score:1.114; JIF Percentile:62.4; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:150; % of Articles in Citable items:0.9; Cited Half-Life:2.4; Citing Half-Life:5.2; % of OA Gold:0.9277; Publisher name:PENN STATE UNIV PRESS; Publisher address:820 NORTH UNIV DRIVE, U S B 1, STE C,
投票 ESCI期刊Pharmaceutical Medicine 2024/2025影響因子:3.111 (PHARM MED) (1178-2595). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging So  ...234
Total Citations:453; 2023 JIF:3.111; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:2.424; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.8; Immediacy Index:0.9; Immediacy Index-dealt:0.976; 2023 JCI:0.76; JCI Rank: 136/354 ; Total Articles:30; JCI Quartile:Q2; JCI Percentile:61.72; Eigenfactor:0.001; Normalized Eigenfactor:0.186; Article Influence Score:0.68; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:44; % of Articles in Citable items:0.6818; Cited Half-Life:3.2; Citing Half-Life:6.9; % of OA Gold:0.4141; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE,
投票 ESCI期刊Advances in Pharmacology and Pharmacy 2024/2025影響因子:0.445 (ADV PHARMACOL PHARM) (2332-0036). (PHARMACOLOGY & PHAR  ...234
Total Citations:77; 2023 JIF:0.445; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.515; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:0.5; Immediacy Index-dealt:0.599; 2023 JCI:0.11; JCI Rank: 337/354 ; Total Articles:27; JCI Quartile:Q4; JCI Percentile:4.94; Eigenfactor:0; Normalized Eigenfactor:0.008; Article Influence Score:0.058; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:31; % of Articles in Citable items:0.871; Cited Half-Life:NULL; Citing Half-Life:10.4; % of OA Gold:1; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 ESCI期刊Current Drug Therapy 2024/2025影響因子:0.377 (CURR DRUG THER) (1574-8855). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging  ...234
Total Citations:224; 2023 JIF:0.377; JIFRank: 344/354 ; Rank-JIF: 344; Number-of-JIF:354; 5 Year JIF:0.649; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:0.1; Immediacy Index-dealt:0.111; 2023 JCI:0.13; JCI Rank: 332/354 ; Total Articles:29; JCI Quartile:Q4; JCI Percentile:6.36; Eigenfactor:0; Normalized Eigenfactor:0.02; Article Influence Score:0.07; JIF Percentile:3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:59; % of Articles in Citable items:0.4915; Cited Half-Life:7.1; Citing Half-Life:8.6; % of OA Gold:0.015; Publisher name:CELL PRESS; Publisher address:50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, USA, MA, 02139;
投票 ESCI期刊Drug Research 2024/2025影響因子:1.753 (DRUG RES) (2194-9379). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging Sources Citat  ...234
Total Citations:1447; 2023 JIF:1.753; JIFRank: 251/354 ; Rank-JIF: 251; Number-of-JIF:354; 5 Year JIF:1.848; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.6; Immediacy Index:0.6; Immediacy Index-dealt:0.677; 2023 JCI:0.36; JCI Rank: 278/354 ; Total Articles:30; JCI Quartile:Q4; JCI Percentile:21.61; Eigenfactor:0.001; Normalized Eigenfactor:0.201; Article Influence Score:0.283; JIF Percentile:29.2; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:46; % of Articles in Citable items:0.6522; Cited Half-Life:5.9; Citing Half-Life:8.5; % of OA Gold:0.0375; Publisher name:OXFORD UNIV PRESS; Publisher address:GREAT CLARENDON ST, OXFORD, ENGLAND, O
投票 ESCI期刊Pharmacy Practice-Granada 2024/2025影響因子:2.482 (PHARM PRACT-GRANADA) (1885-642X). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué)  ...234
Total Citations:1440; 2023 JIF:2.482; JIFRank: 188/354 ; Rank-JIF: 188; Number-of-JIF:354; 5 Year JIF:2.564; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.3; Immediacy Index:0.2; Immediacy Index-dealt:0.259; 2023 JCI:0.65; JCI Rank: 177/354 ; Total Articles:77; JCI Quartile:Q2; JCI Percentile:50.14; Eigenfactor:0.001; Normalized Eigenfactor:0.316; Article Influence Score:0.517; JIF Percentile:47; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:85; % of Articles in Citable items:0.9059; Cited Half-Life:4.9; Citing Half-Life:6.9; % of OA Gold:0.9913; Publisher name:GEMMOLOGICAL ASSOC GREAT BRITAIN; Publisher address:21 ELY PLACE, LONDON, ENG
投票 ESCI期刊Therapeutic Delivery 2024/2025影響因子:3.157 (THER DELIV) (2041-5990). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging Sour  ...234
Total Citations:2566; 2023 JIF:3.157; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:3.762; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.5; Immediacy Index:0.6; Immediacy Index-dealt:0.686; 2023 JCI:0.7; JCI Rank: 163/354 ; Total Articles:27; JCI Quartile:Q2; JCI Percentile:54.1; Eigenfactor:0.001; Normalized Eigenfactor:0.206; Article Influence Score:0.535; JIF Percentile:61.7; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:53; % of Articles in Citable items:0.5094; Cited Half-Life:7.8; Citing Half-Life:7.5; % of OA Gold:0.094; Publisher name:CAMBRIDGE UNIV PRESS; Publisher address:EDINBURGH BLDG, SHAFTESBURY RD, CAMBRI
投票 ESCI期刊Journal of Pharmaceutical Health Care and Sciences 2024/2025影響因子:1.209 (J PHARM HEALTH CARE) (2055-0294). (PHARMA  ...234
Total Citations:400; 2023 JIF:1.209; JIFRank: 290/354 ; Rank-JIF: 290; Number-of-JIF:354; 5 Year JIF:1.412; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.2; Immediacy Index:0.2; Immediacy Index-dealt:0.289; 2023 JCI:0.36; JCI Rank: 278/354 ; Total Articles:48; JCI Quartile:Q4; JCI Percentile:21.61; Eigenfactor:0.001; Normalized Eigenfactor:0.112; Article Influence Score:0.36; JIF Percentile:18.2; JIF Quartile:Q4; AIS Quartile:Q3; Citable Items:50; % of Articles in Citable items:0.96; Cited Half-Life:4.7; Citing Half-Life:9.3; % of OA Gold:1; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 ESCI期刊Journal of Pharmaceutical Policy and Practice 2024/2025影響因子:3.391 (J PHARM POLICY PRACT) (NULL). (PHARMACOLOGY &  ...234
Total Citations:1370; 2023 JIF:3.391; JIFRank: 118/354 ; Rank-JIF: 118; Number-of-JIF:354; 5 Year JIF:3.772; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3; Immediacy Index:0.6; Immediacy Index-dealt:0.624; 2023 JCI:0.96; JCI Rank: 91/354 ; Total Articles:143; JCI Quartile:Q2; JCI Percentile:74.44; Eigenfactor:0.002; Normalized Eigenfactor:0.442; Article Influence Score:0.835; JIF Percentile:66.8; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:163; % of Articles in Citable items:0.8773; Cited Half-Life:3; Citing Half-Life:6; % of OA Gold:1; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Reviews on Recent Clinical Trials 2024/2025影響因子:1.468 (REV RECENT CLIN TRIA) (1574-8871). (PHARMACOLOGY & PHARMAC  ...234
Total Citations:592; 2023 JIF:1.468; JIFRank: 275/354 ; Rank-JIF: 275; Number-of-JIF:354; 5 Year JIF:1.552; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.3; Immediacy Index:0.5; Immediacy Index-dealt:0.518; 2023 JCI:0.36; JCI Rank: 278/354 ; Total Articles:23; JCI Quartile:Q4; JCI Percentile:21.61; Eigenfactor:0.001; Normalized Eigenfactor:0.123; Article Influence Score:0.346; JIF Percentile:22.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:34; % of Articles in Citable items:0.6765; Cited Half-Life:5.9; Citing Half-Life:6.8; % of OA Gold:0.0244; Publisher name:SPRINGER; Publisher address:VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS,
投票 ESCI期刊Asian Journal of Pharmaceutical Research and Health Care 2024/2025影響因子:0.203 (ASIAN J PHARM RES HE) (2250-1444).  ...234
Total Citations:81; 2023 JIF:0.203; JIFRank: 350/354 ; Rank-JIF: 350; Number-of-JIF:354; 5 Year JIF:0.253; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.033; 2023 JCI:0.08; JCI Rank: 344/354 ; Total Articles:56; JCI Quartile:Q4; JCI Percentile:2.97; Eigenfactor:0; Normalized Eigenfactor:0.008; Article Influence Score:0.036; JIF Percentile:1.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:61; % of Articles in Citable items:0.918; Cited Half-Life:NULL; Citing Half-Life:8.6; % of OA Gold:0.9771; Publisher name:LIPPINCOTT WILLIAMS & WILKINS; Publisher address:TWO COMMERCE SQ, 2001 MARKET ST,
投票 ESCI期刊Journal of Cannabis Research 2024/2025影響因子:4.172 (J CANNABIS RES) (NULL). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emergi  ...234
Total Citations:615; 2023 JIF:4.172; JIFRank: 78/354 ; Rank-JIF: 78; Number-of-JIF:354; 5 Year JIF:3.875; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.9; Immediacy Index:1; Immediacy Index-dealt:1.141; 2023 JCI:0.97; JCI Rank: 88/354 ; Total Articles:32; JCI Quartile:Q1; JCI Percentile:75.28; Eigenfactor:0.001; Normalized Eigenfactor:0.241; Article Influence Score:0.869; JIF Percentile:78.1; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:35; % of Articles in Citable items:0.9143; Cited Half-Life:2.4; Citing Half-Life:5.6; % of OA Gold:1; Publisher name:AMER INST MATHEMATICAL SCIENCES-AIMS; Publisher address:PO BOX 2604, SPRINGFIELD, Unit
投票 ESCI期刊Indonesian Journal of Pharmacy 2024/2025影響因子:0.782 (INDONES J PHARM) (2338-9486). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥  ...234
Total Citations:249; 2023 JIF:0.782; JIFRank: 317/354 ; Rank-JIF: 317; Number-of-JIF:354; 5 Year JIF:0.713; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.6; Immediacy Index:0.1; Immediacy Index-dealt:0.158; 2023 JCI:0.11; JCI Rank: 337/354 ; Total Articles:44; JCI Quartile:Q4; JCI Percentile:4.94; Eigenfactor:0; Normalized Eigenfactor:0.031; Article Influence Score:0.082; JIF Percentile:10.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:45; % of Articles in Citable items:0.9778; Cited Half-Life:4.6; Citing Half-Life:6.8; % of OA Gold:0.4014; Publisher name:EUROPEAN RESPIRATORY SOC JOURNALS LTD; Publisher address:442 GLOSSOP RD, SHEFFIEL
投票 ESCI期刊Journal of Dietary Supplements 2024/2025影響因子:1.906 (J DIET SUPPL) (1939-0211). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))E  ...234
Total Citations:1229; 2023 JIF:1.906; JIFRank: 231/354 ; Rank-JIF: 231; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:1.9; Immediacy Index:0.6; Immediacy Index-dealt:0.632; 2023 JCI:0.52; JCI Rank: 227/354 ; Total Articles:21; JCI Quartile:Q3; JCI Percentile:36.02; Eigenfactor:0.001; Normalized Eigenfactor:0.053; Article Influence Score:0.081; JIF Percentile:34.9; JIF Quartile:Q3; AIS Quartile:NULL; Citable Items:27; % of Articles in Citable items:0.7778; Cited Half-Life:4.9; Citing Half-Life:8.4; % of OA Gold:0.2051; Publisher name:OXFORD UNIV PRESS; Publisher address:GREAT CLARENDON ST, OXFORD, ENGLAND
投票 ESCI期刊Journal of Research in Pharmacy Practice 2024/2025影響因子:0.814 (J RES PHARM PRACT) (2319-9644). (PHARMACOLOGY & PHA  ...234
Total Citations:500; 2023 JIF:0.814; JIFRank: 311/354 ; Rank-JIF: 311; Number-of-JIF:354; 5 Year JIF:1.201; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.8; Immediacy Index:<0.1; Immediacy Index-dealt:0.093; 2023 JCI:0.25; JCI Rank: 303/354 ; Total Articles:5; JCI Quartile:Q4; JCI Percentile:14.55; Eigenfactor:0; Normalized Eigenfactor:0.071; Article Influence Score:0.261; JIF Percentile:12.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:5; % of Articles in Citable items:1; Cited Half-Life:6.9; Citing Half-Life:NULL; % of OA Gold:0.8868; Publisher name:IOP PUBLISHING LTD; Publisher address:TEMPLE CIRCUS, TEMPLE WAY, BRISTOL, ENGLAND, BS
投票 ESCI期刊Journal of Pharmacy and Bioallied Sciences 2024/2025影響因子:0.708 (J PHARM BIOALLIED SC) (0976-4879). (PHARMACOLOGY  ...234
Total Citations:3434; 2023 JIF:0.708; JIFRank: 317/354 ; Rank-JIF: 317; Number-of-JIF:354; 5 Year JIF:1.293; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.7; Immediacy Index:0.1; Immediacy Index-dealt:0.107; 2023 JCI:0.2; JCI Rank: 319/354 ; Total Articles:317; JCI Quartile:Q4; JCI Percentile:10.03; Eigenfactor:0.002; Normalized Eigenfactor:0.384; Article Influence Score:0.19; JIF Percentile:10.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:350; % of Articles in Citable items:0.9057; Cited Half-Life:8; Citing Half-Life:12.1; % of OA Gold:0.9811; Publisher name:INDERSCIENCE ENTERPRISES LTD; Publisher address:WORLD TRADE CENTER BLDG, 29
投票 ESCI期刊Actualites Pharmaceutiques 2024/2025影響因子:0.124 (ACTUAL PHARMACEUT) (0515-3700). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))  ...234
Total Citations:72; 2023 JIF:0.124; JIFRank: 352/354 ; Rank-JIF: 352; Number-of-JIF:354; 5 Year JIF:0.199; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.086; 2023 JCI:0.03; JCI Rank: 350/354 ; Total Articles:103; JCI Quartile:Q4; JCI Percentile:1.27; Eigenfactor:0; Normalized Eigenfactor:0.01; Article Influence Score:0.009; JIF Percentile:0.7; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:111; % of Articles in Citable items:0.9279; Cited Half-Life:NULL; Citing Half-Life:6.6; % of OA Gold:0.3524; Publisher name:INT MUSICOLOGICAL SOC; Publisher address:BOX 561, BASEL, SWITZERLAND, CH-4001;
下一頁(yè) »
1234下一頁(yè)
返 回
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 06:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
返回頂部 返回版塊
永泰县| 吴桥县| 巴林左旗| 阳泉市| 乌拉特后旗| 沂源县| 扎囊县| 山东省| 墨江| 永康市| 大冶市| 清远市| 新宁县| 商水县| 大英县| 西乡县| 宜兴市| 富宁县| 高雄市| 海门市| 松阳县| 凤山县| 加查县| 西充县| 平安县| 商洛市| 金阳县| 大邑县| 兴仁县| 万载县| 天长市| 滨州市| 长海县| 新宾| 香格里拉县| 海南省| 岳西县| 高陵县| 商河县| 永平县| 五台县|